Matches in Wikidata for { <http://www.wikidata.org/entity/Q85233379> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q85233379 description "artículu científicu espublizáu n'agostu de 2014" @default.
- Q85233379 description "im August 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85233379 description "scientific article published on 30 August 2014" @default.
- Q85233379 description "wetenschappelijk artikel" @default.
- Q85233379 description "наукова стаття, опублікована в серпні 2014" @default.
- Q85233379 name "In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability" @default.
- Q85233379 name "In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability" @default.
- Q85233379 type Item @default.
- Q85233379 label "In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability" @default.
- Q85233379 label "In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability" @default.
- Q85233379 prefLabel "In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability" @default.
- Q85233379 prefLabel "In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability" @default.
- Q85233379 P1433 Q85233379-D4A9F402-D494-437B-9F0E-22F95F2CEB88 @default.
- Q85233379 P1476 Q85233379-406BD7AE-0931-454C-9F22-75F0B9D4DB5D @default.
- Q85233379 P2093 Q85233379-10264810-959A-48E3-B190-DE8B80936AFA @default.
- Q85233379 P2093 Q85233379-118E2897-A339-48E4-81F0-B04F25E60B25 @default.
- Q85233379 P2093 Q85233379-7B508C71-8CA2-408B-9A0F-05FDE0A2E541 @default.
- Q85233379 P2093 Q85233379-AB3ADC38-9226-43AC-96B2-C51DE2AB6A5D @default.
- Q85233379 P304 Q85233379-5079637C-0208-456F-A9C1-5176774D7EE1 @default.
- Q85233379 P31 Q85233379-E44899BC-0C0F-43F6-B667-AF7AEB03FFC5 @default.
- Q85233379 P356 Q85233379-9783E571-0CF7-4397-BAB5-293BCCC8F6E0 @default.
- Q85233379 P433 Q85233379-23A7B6C4-7CBC-44AF-9ABB-E95851F08FF8 @default.
- Q85233379 P478 Q85233379-FCC2E341-4E66-488C-98F0-FA7B41C3FB42 @default.
- Q85233379 P50 Q85233379-B30A9FF9-B287-44AE-BACF-310BBB7FD166 @default.
- Q85233379 P577 Q85233379-5F9C27DE-4F61-41DA-977D-0265D491C7C0 @default.
- Q85233379 P698 Q85233379-AE5F1D3F-6234-462D-9F95-E5D575165812 @default.
- Q85233379 P356 J.BCMD.2014.07.017 @default.
- Q85233379 P698 25179834 @default.
- Q85233379 P1433 Q15758051 @default.
- Q85233379 P1476 "In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability" @default.
- Q85233379 P2093 "Carina Schubiger" @default.
- Q85233379 P2093 "Elisabeth I Minder" @default.
- Q85233379 P2093 "Gianfranco Biolcati" @default.
- Q85233379 P2093 "Xiaoye Schneider-Yin" @default.
- Q85233379 P304 "71-77" @default.
- Q85233379 P31 Q13442814 @default.
- Q85233379 P356 "10.1016/J.BCMD.2014.07.017" @default.
- Q85233379 P433 "1" @default.
- Q85233379 P478 "54" @default.
- Q85233379 P50 Q56480319 @default.
- Q85233379 P577 "2014-08-30T00:00:00Z" @default.
- Q85233379 P698 "25179834" @default.